{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-072065","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.667815+00:00","generated_at":"2026-05-17T20:48:19.844105+00:00","sec_items":["1.01","3.02","8.01","3.20","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"180 Life Sciences closes $425M private placement to fund Ethereum treasury strategy","bullets":["Raised $425M gross via PIPE at $2.65 per share; closed Aug 4, 2025.","Proceeds to buy ETH and implement on-chain yield generation via staking, lending, liquidity.","Board reshuffled: McAndrew Rudisill appointed Chairman; independent directors Crystal Heter and Andrew Suckling added.","Dr. Lawrence Steinman resigned as director effective Aug 4, no disagreement.","Company also exploring up to $150M fixed-income securities offering, subject to definitive docs."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-072065","json":"https://secwatch.observer/filing/0001213900-25-072065.json","markdown":"https://secwatch.observer/filing/0001213900-25-072065.md","text":"https://secwatch.observer/filing/0001213900-25-072065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390025072065/0001213900-25-072065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390025072065/ea0251165-8k_180life.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:48:19.844105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}